Literature DB >> 2642485

Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss.

R Pasquali1, D Antenucci, F Casimirri, S Venturoli, R Paradisi, R Fabbri, V Balestra, N Melchionda, L Barbara.   

Abstract

We studied a group of obese hyperandrogenic amenorrheic women to determine the effects of weight loss on anthropometry, hormonal status, menstrual cycles, ovulation, and fertility. Fourteen women had polycystic ovaries, two the hyperandrogenism-insulin resistance-acanthosis nigricans syndrome, one hirsutism of adrenal origin, and three idiopathic chronic anovulation. The duration of amenorrhea before the study ranged from 3-17 months [mean, 8.6 +/- 4.5 (+/- SD)]. All women ate a hypocaloric diet for a period of 8.0 +/- 2.4 months. Weight loss ranged from 4.8 to 15.2 kg (mean, 9.7 +/- 3.1 kg; 1.35 +/- 0.56 kg/month) and the waist to hip ratio, which was used as a measurement of body fat distribution, decreased from 0.86 +/- 0.1 to 0.81 +/- 0.06 (P less than 0.0001). The women's mean plasma testosterone and LH concentrations decreased significantly (P less than 0.001 and P less than 0.005, respectively). A significant positive correlation was found between the decreases in plasma testosterone levels and the decreases in glucose-stimulated insulin levels. Moreover, the decreases in the waist to hip ratio correlated positively with the decreases in glucose-stimulated insulin levels and inversely with the decreases in plasma 17 beta-estradiol. No relationships were found between weight loss and the changes in plasma insulin, steroid, and gonadotropin concentrations. The responsiveness to the weight reduction program was evaluated by comparing the number of menstrual cycles during the study period with the number reported before it. Eight women had significantly improved menstrual cyclicity (responders), while 12 did not (nonresponders). The clinical characteristics and hormone values were similar in responder and nonresponder women. In the group as a whole, 33% of the menstrual cycles during the study were ovulatory, and 4 pregnancies occurred. Hirsutism improved significantly in more than half of the women, as did acanthosis nigricans when present. We conclude that weight loss is beneficial in all obese hyperandrogenic women regardless of the presence of polycystic ovaries, the degree of hyperandrogenism, and the degree and distribution of obesity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2642485     DOI: 10.1210/jcem-68-1-173

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  46 in total

Review 1.  ACP Broadsheet 131: March 1992. Hirsute women: should they be investigated?

Authors:  J H Barth
Journal:  J Clin Pathol       Date:  1992-03       Impact factor: 3.411

2.  Should obese women with polycystic ovary syndrome receive treatment for infertility?

Authors:  Adam H Balen; Martin Dresner; Eleanor M Scott; James O Drife
Journal:  BMJ       Date:  2006-02-25

3.  Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile.

Authors:  E Zulian; P Sartorato; S Benedini; G Baro; D Armanini; F Mantero; C Scaroni
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

Review 4.  How actual is the dietary treatment in overweighting patients with polycystic ovary syndrome?

Authors:  C Cortet-Rudelli; D Dewailly
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

Review 5.  New routes in the polycystic ovary syndrome labyrinth: a way out?

Authors:  P Moghetti; R Castello
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

6.  Metabolic, behavioral, and reproductive effects of vertical sleeve gastrectomy in an obese rat model of polycystic ovary syndrome.

Authors:  Ilana B Ressler; Bernadette E Grayson; Randy J Seeley
Journal:  Obes Surg       Date:  2014-06       Impact factor: 4.129

7.  Moderate energy restriction with high protein diet results in healthier outcome in women.

Authors:  Antti A Mero; Heikki Huovinen; Olle Matintupa; Juha J Hulmi; Risto Puurtinen; Hannele Hohtari; Tuomo Am Karila
Journal:  J Int Soc Sports Nutr       Date:  2010-01-25       Impact factor: 5.150

8.  Chronic combined hyperandrogenemia and western-style diet in young female rhesus macaques causes greater metabolic impairments compared to either treatment alone.

Authors:  C A True; D L Takahashi; S E Burns; E C Mishler; K R Bond; M C Wilcox; A R Calhoun; L A Bader; T A Dean; N D Ryan; O D Slayden; J L Cameron; R L Stouffer
Journal:  Hum Reprod       Date:  2017-09-01       Impact factor: 6.918

9.  Combined androgen excess and Western-style diet accelerates adipose tissue dysfunction in young adult, female nonhuman primates.

Authors:  Oleg Varlamov; Cecily V Bishop; Mithila Handu; Diana Takahashi; Sathya Srinivasan; Ashley White; Charles T Roberts
Journal:  Hum Reprod       Date:  2017-09-01       Impact factor: 6.918

10.  Current trends in the treatment of polycystic ovary syndrome with desire for children.

Authors:  Margalida E Sastre; Maria O Prat; Miguel Angel Checa; Ramon C Carreras
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.